Regulus Therapeutics, a biopharmaceutical company focused on the discovery and development of medicines targeting microRNAs, has appointed Mohammad Ahmadian as Vice President of Chemistry and Pharmaceutical Development. The role In his role, Dr. Ahmadian will assist in managing research and development of the company’s drug candidates, including RGLS8429, which is being developed for patients with […]